IRIS
LOSURDO, GIUSEPPE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.978
AS - Asia 2.967
EU - Europa 2.591
SA - Sud America 717
Continente sconosciuto - Info sul continente non disponibili 613
AF - Africa 118
OC - Oceania 7
Totale 16.991
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.669
SG - Singapore 1.168
IT - Italia 910
CN - Cina 583
BR - Brasile 566
RU - Federazione Russa 391
HK - Hong Kong 373
SE - Svezia 334
DE - Germania 250
VN - Vietnam 245
GB - Regno Unito 167
FR - Francia 154
CA - Canada 130
BD - Bangladesh 111
FI - Finlandia 102
IN - India 96
ID - Indonesia 58
IQ - Iraq 57
BE - Belgio 51
AR - Argentina 49
MX - Messico 45
TR - Turchia 44
NL - Olanda 41
PL - Polonia 37
CO - Colombia 34
ES - Italia 32
ZA - Sudafrica 32
PK - Pakistan 31
UA - Ucraina 28
EC - Ecuador 24
SA - Arabia Saudita 22
UZ - Uzbekistan 22
JP - Giappone 21
TT - Trinidad e Tobago 21
IL - Israele 20
CR - Costa Rica 18
GT - Guatemala 17
IE - Irlanda 17
MA - Marocco 14
NI - Nicaragua 14
EG - Egitto 13
PH - Filippine 13
VE - Venezuela 13
HN - Honduras 12
MY - Malesia 12
AT - Austria 11
CI - Costa d'Avorio 11
CW - ???statistics.table.value.countryCode.CW??? 11
DZ - Algeria 11
PE - Perù 10
AE - Emirati Arabi Uniti 9
AZ - Azerbaigian 9
JM - Giamaica 9
JO - Giordania 9
PR - Porto Rico 9
TN - Tunisia 9
AL - Albania 8
CL - Cile 8
GP - Guadalupe 8
SV - El Salvador 8
GR - Grecia 7
KE - Kenya 7
KZ - Kazakistan 7
RO - Romania 7
AU - Australia 6
CH - Svizzera 6
KR - Corea 6
LB - Libano 6
LT - Lituania 6
NP - Nepal 6
TH - Thailandia 6
BB - Barbados 5
BO - Bolivia 5
EU - Europa 5
PS - Palestinian Territory 5
PY - Paraguay 5
QA - Qatar 5
BG - Bulgaria 4
MK - Macedonia 4
PA - Panama 4
SC - Seychelles 4
AG - Antigua e Barbuda 3
CZ - Repubblica Ceca 3
DO - Repubblica Dominicana 3
EE - Estonia 3
ET - Etiopia 3
GA - Gabon 3
GE - Georgia 3
KG - Kirghizistan 3
LV - Lettonia 3
MD - Moldavia 3
OM - Oman 3
TW - Taiwan 3
AM - Armenia 2
BA - Bosnia-Erzegovina 2
BW - Botswana 2
DK - Danimarca 2
IR - Iran 2
KW - Kuwait 2
SN - Senegal 2
Totale 16.367
Salva come PNG Salva come JPEG
Città #
Ashburn 1.021
Fairfield 869
Woodbridge 627
Singapore 617
San Jose 503
Chandler 449
Houston 380
Hong Kong 369
Seattle 343
Milan 306
Wilmington 299
Cambridge 293
Ann Arbor 286
Nyköping 278
Council Bluffs 236
New York 219
Beijing 214
Dallas 193
Los Angeles 134
Rome 102
Santa Clara 99
Jacksonville 90
Lawrence 89
Roxbury 85
Lauterbourg 79
Ho Chi Minh City 75
Nanjing 67
Boardman 65
Munich 60
Atlanta 58
Des Moines 56
Bari 55
Brooklyn 54
Helsinki 54
Inglewood 54
Columbus 53
Brussels 51
São Paulo 49
Chicago 45
Hanoi 45
Denver 41
Buffalo 39
Princeton 39
San Francisco 39
Orem 37
Jakarta 35
Montreal 35
Phoenix 33
Frankfurt am Main 32
San Diego 32
Dearborn 31
Warsaw 30
Turin 29
North Bergen 28
London 26
Falkenstein 23
Nuremberg 22
Bologna 21
Toronto 21
Baghdad 20
Dhaka 20
Mexico City 20
Dong Ket 19
Figino 19
Rio de Janeiro 19
Stockholm 19
Tokyo 19
Hebei 18
Paris 18
Tashkent 18
Belo Horizonte 17
Haiphong 17
Johannesburg 17
The Dalles 17
Dublin 16
Nanchang 16
Boston 15
San José 15
Chennai 14
Istanbul 14
Jiaxing 14
Medellín 14
Palermo 14
Tianjin 14
Brasília 13
Managua 13
Naples 13
Shenyang 13
Philadelphia 12
Pune 12
Abidjan 11
Curitiba 11
Da Nang 11
Lahore 11
Willemstad 11
Amsterdam 10
Cairo 10
Guatemala City 10
Chaguanas 9
Florence 9
Totale 10.216
Salva come PNG Salva come JPEG
Nome #
Effect of Long-Term Proton Pump Inhibitor Use on Blood Vitamins and Minerals: A Primary Care Setting Study 1.099
Extra-intestinal manifestations of non-celiac gluten sensitivity: An expanding paradigm 288
Breath tests for the non-invasive diagnosis of small intestinal bacterial overgrowth: A systematic review with meta-analysis 263
Concomitant and Bismuth Quadruple Therapy for Helicobacter pylori Eradication in Southern Italy: Preliminary Data from a Randomized Clinical Trial 259
Nonalcoholic Fatty Liver Disease in Inflammatory Bowel Disease: Prevalence and Risk Factors 223
Differences in dietary habits between patients with inflammatory bowel disease in clinical remission and a healthy population 221
Small intestinal bacterial overgrowth and celiac disease: A systematic review with pooled-data analysis 220
Chemoprevention of inflammation-related colorectal cancer by silymarin-, acetyl-11-keto-beta-boswellic acid-, curcumin- and maltodextrin-enriched dietetic formulation in animal model 208
Gastrointestinal bleeding from vascular malformations: Is octreotide effective to rescue difficult-to-treat patients? 206
Systematic review with meta-analysis: post-operative complications and mortality risk in liver transplant candidates with obesity. 206
Evolution of nonspecific duodenal lymphocytosis over 2 years of follow-up 205
Systematic review: Renin-angiotensin system inhibitors in chemoprevention of hepatocellular carcinoma 201
May the assessment of baseline mucosal molecular pattern predict the development of gluten related disorders among microscopic enteritis? 199
Curcumin and colorectal cancer: From basic to clinical evidences 183
Tailored therapy guided by multichannel intraluminal impedance pH monitoring for refractory non-erosive reflux disease 180
The helper lymphocyte and mast cell immunohistochemical pattern in nonceliac gluten sensitivity 177
The influence of small intestinal bacterial overgrowth in digestive and extra-intestinal disorders 167
Stool Investigations for Colorectal Cancer Screening: From Occult Blood Test to DNA Analysis 160
What Is the Optimal Follow-up Time to Ascertain the Safety of Proton Pump Inhibitors? 156
Fibrogenesis and fibrosis in inflammatory bowel diseases: Good and bad side of same coin? 155
Non steroidal anti-inflammatory drug induced damage on lower gastro-intestinal tract: is there an involvement of microbiota? 154
Inter-observer agreement of a new endoscopic score for ulcerative colitis activity: Preliminary experience 153
Chronic viral hepatitis in a cohort of inflammatory bowel disease patients from southern Italy: A case-control study 153
Predictivity of Autoimmune Stigmata for Gluten Sensitivity in Subjects with Microscopic Enteritis: A Retrospective Study 148
Helicobacter pylori primary and secondary genotypic resistance to clarithromycin and levofloxacin detection in stools: A 4-year scenario in Southern Italy 148
Comparison of Transient Elastography and Point Shear Wave Elastography for Analysis of Liver Stiffness: A Prospective Study 146
Intestinal microbiota: The explosive mixture at the origin of inflammatory bowel disease? 144
Prevalence and associated factors of obesity in inflammatory bowel disease: A case-control study 136
Acute pancreatitis in elderly patients: A retrospective evaluation at hospital admission 133
Lymphocytic duodenitis or microscopic enteritis and gluten-related conditions: What needs to be explored? 131
Serrated Colorectal Lesions: An Up-to-Date Review from Histological Pattern to Molecular Pathogenesis 129
An uncommon etiology of pancreatitis after endoscopic ultrasound-guided fine needle aspiration 128
Escherichia coli Nissle 1917 in ulcerative colitis treatment: Systematic review and meta-analysis 128
Seronegative celiac disease: where is the specific setting? 125
Silymarin, boswellic acid and curcumin enriched dietetic formulation reduces the growth of inherited intestinal polyps in an animal model 125
Systematic review with meta-analysis: de novo non-alcoholic fatty liver disease in liver-transplanted patients 124
Optimizing proton pump inhibitors in Helicobacter pylori treatment: Old and new tricks to improve effectiveness 124
Checkpoint Inhibitor-Induced Colitis: An Update 123
Assessment of body composition: Intrinsic methodological limitations and statistical pitfalls 122
The puzzle of coccoid forms of helicobacter pylori: Beyond basic science 121
Histamine and histaminergic receptors in colorectal cancer: From basic science to evidence-based medicine 120
Human leukocyte antigen (Hla) haplotype does not influence the inflammatory pattern of duodenal lymphocytosis linked to irritable bowel syndrome 116
A case of severe transaminase elevation following a single ustekinumab dose with remission after drug withdrawal 112
Might helicobacter pylori play a role in allergic or cross-reaction related disorders? 111
Role of concomitant therapy for Helicobacter pylori eradication: A technical note 110
Endoscopic stenting for colorectal cancer obstruction as a bridge-to-surgery strategy 110
Low Molecular Weight Heparin in Portal Vein Thrombosis of Cirrhotic Patients: Only Therapeutic Purposes? 108
The spectrum of small intestinal lesions in patients with unexplained iron deficiency anemia detected by video capsule endoscopy 105
Liver involvement in inflammatory bowel disease: What should the clinician know? 104
Estrogen receptors in colorectal cancer: Facts, novelties and perspectives 103
null 101
Trends of Liver Stiffness in Inflammatory Bowel Disease with Chronic Hepatitis C 101
null 100
Endothelial function and cardiovascular risk in patients with inflammatory bowel disease in remission phase 100
null 99
Molecular Pathways of Carcinogenesis in Familial Adenomatous Polyposis 98
Noninvasive molecular analysis of Helicobacter pylori: is it time for tailored first-line therapy? 97
Primary clarithromycin resistance to Helicobacter pylori: Is this the main reason for triple therapy failure? 97
Biological markers for non-celiac gluten sensitivity: A question awaiting for a convincing answer 97
A prospective trial in Saudi Arabia comparing the 14-day standard triple therapy with the 10-day sequential therapy for treatment of Helicobacter pylori infection: A further confirmation of geographic Weight 96
Empiric “Three-in-One” Bismuth Quadruple Therapy for Second-Line Helicobacter pylori Eradication: An Intervention Study in Southern Italy 95
null 94
Rifabutin as salvage therapy for Helicobacter pylori eradication: Cornerstones and novelties 93
Validation of a new optical diagnosis training module to improve dysplasia characterization in inflammatory bowel disease: a multicenter international study 92
Familial intestinal polyposis and device assisted enteroscopy: where do we stand? 91
Letter: Portal vein obstruction - Which subset of patients could benefit the most? 91
Does infliximab short infusion have a beneficial impact on the quality of life in patients with inflammatory bowel diseases? A single centre prospective evaluation 91
Editorial: liver transplantation in patients with non-alcoholic fatty liver disease and obesity—authors’ reply 91
Empirical Second-Line Therapy in 5000 Patients of the European Registry on Helicobacter pylori Management (Hp-EuReg) 90
Effect of metronidazole resistance on Helicobacter pylori eradication regimens 89
Familial adenomatous polyposis small bowel surveillance: could indicators for video-capsule endoscopy be ascertained? 89
Epstein-Barr Virus-Related hyperacute hepatitis: May intravenous Ster-Oids be an effective approach? 87
Helicobacter pylori Secondary Antibiotic Resistance after One or More Eradication Failure: A Genotypic Stool Analysis Study 87
Second-line Therapy for Helicobacter Pylori Eradication: State of the Art 86
null 86
null 86
Mucosal molecular pattern of tissue transglutaminase and interferon gamma in suspected seronegative celiac disease at marsh 1 and 0 stages 86
Hydradenitis suppurativa and inflammatory bowel disease: An unusual, but existing association 86
null 85
Probiotic monotherapy and Helicobacter pylori eradication: A systematic review with pooled-data analysis 85
Experience with Rifabutin-Containing Therapy in 500 Patients from the European Registry on Helicobacter pylori Management (Hp-EuReg) 84
Fibres and Colorectal Cancer: Clinical and Molecular Evidence 84
Sequential therapy for helicobacter pylori in elderly patients: Effectiveness, safety and predictors of success 84
Letter: dose-response analysis revealed closer relationship between obesity and perioperative outcomes in patients after liver transplantation—Authors’ reply 84
Effect of Visual Booklets to Improve Bowel Preparation in Colonoscopy: Systematic Review with Meta-Analysis 83
null 82
Extra Virgin Olive Oil Reduces the Risk of Non-Alcoholic Fatty Liver Disease in Females but Not in Males: Results from the NUTRIHEP Cohort 81
null 81
null 81
Detection of Helicobacter pylori DNA sequences in gastric biopsy samples to refine the diagnosis and therapy 81
Primary biliary cholangitis triggered by DAAs-induced HCV clearance: a biological proof of concept 81
null 80
null 79
null 79
Transmission electron microscopy helpfulness in Whipple's disease masked by immunosuppressant therapy for arthritis 79
Letter: Tumour necrosis factor alpha blocker switching - A not so simple pharmacokinetic 77
QUADRUPLE RESCUE THERAPY AFTER FIRST AND SECOND LINE FAILURE FOR HELICOBACTER PYLORI TREATMENT: COMPARISON BETWEEN TWO TETRACYCLINE-BASED REGIMENS 76
Intestinal microbiota: the explosive mixture for inflammatory bowel disease pathogenesis? 75
The State of the Art of Molecular Fecal Investigations for Helicobacter pylori (H. pylori) Antibiotic Resistances 75
null 74
Totale 13.136
Salva come PNG Salva come JPEG
Categoria #
all - tutte 64.492
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 64.492
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022563 0 0 0 0 45 70 20 32 52 62 115 167
2022/20231.115 148 187 85 74 90 169 21 134 152 5 32 18
2023/2024416 29 69 16 47 26 137 6 7 2 34 8 35
2024/20252.039 56 25 106 32 38 183 297 210 93 136 285 578
2025/20265.419 724 242 332 470 641 215 484 149 785 576 209 592
2026/20273.021 826 400 648 1.033 114 0 0 0 0 0 0 0
Totale 16.991